Compare Kenvue Inc. Common Stock (KVUE) vs VanEck Uranium & Nuclear ETF (NLR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs VanEck Uranium & Nuclear ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while VanEck Uranium & Nuclear ETF trades at $103.5 (market cap $3.51B). The key difference: Kenvue Inc. Common Stock is far larger — about 9.7× VanEck Uranium & Nuclear ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while VanEck Uranium & Nuclear ETF pays none. Which is the better fit depends on your goals.
| KVUE | NLR | |
|---|---|---|
Market Cap | $34.06B | $3.51B |
Volume | 23,267,228 | 414,516 |
Sector | Consumer Staples | Sector/Thematic |
52-Week High | $19.83 | $164.37 |
52-Week Low | $14.11 | $102.38 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 8 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About VanEck Uranium & Nuclear ETF
VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.
Read more on NLR →
